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Summary: Information on the stability of serum analytes during storage of serum or whole blood samples is often
incomplete and sometimes contradictory. Using a widely available analyser (Hitachi 737/Boehringer), we therefore
determined the effects of storage time and temperature on the measured concentrations of the following serum
analytes: sodium, potassium, calcium, chloride, inorganic phosphate, magnesium, creatinine, urea, uric acid, biliru-
bin, cholesterol, HDL- and LDL-cholesterol, triacylglycerols, creatine kinase, aspartate aminotransferase, alanine
aminotransferase, -glutamyltransferase, alkaline phosphatase, -amylase, lactate dehydrogenase and cholinesterase.
When separated serum was stored at + 9 °C for seven days, the mean changes in inorganic phosphate and lactate
dehydrogenase exceeded significantly (p < 0.05 or 0.001, respectively) the maximum allowable inaccuracy accord-
ing to the Guidelines of the German Federal Medical Council; all other quantities were sufficiently stable.
In serum at room temperature, inorganic phosphate, uric acid, HDL-cholesterol and triacylglycerols increased con-
tinuously, whereas bilirubin, LDL-cholesterol, creatine kinase and aspartate aminotransferase decreased more than
the guidelines permit during the storage period (p < 0.05 for aspartate aminotransferase, p < 0.001 for the other
analytes mentioned).
In whole blood stored for 7 days at + 9 °C, only the following serum analytes satisfied the stability requirements
of the guidelines: calcium, urea, cholesterol, HDL-cholesterol, LDL-cholesterol, triacylglycerols, creatine kinase,
-glutamyltransferase and cholinesterase. When stored at room temperature, only sodium, uric acid, bilirubin, cho-
lesterol, triacylglycerols, aspartate aminotransferase, alanine aminotransferase, alkaline phosphatase, -amylase and
cholinesterase were still stable after 3 days.
The data collected show that all quantities examined are sufficiently stable for four days in separated serum stored
at + 9 °C.
Introduction molysis strongly depends on the methods employed and
the various modifications of a given method. Therefore
we determined the effects of storage time and temper-
A general problem in clinical laboratories is the stability ature on the measurement of the following serum ana-
of analytes during sample storage. Analytical methods lytes: sodium, potassium, calcium, chloride, inorganic
have been continuously optimised to minimise the influ- phosphate, magnesium, creatinine, urea, uric acid, bili-
ence of disturbing factors. In earlier studies, information rubin, cholesterol, HDL-cholesterol, LDL-cholesterol,
on the stability of analytes in serum and whole blood triacylglycerols, creatine kinase (EC 2.7.3.2), aspartate
was based on methods, which have since become obso- aminotransferase (EC 2.6.1.1), alanine aminotransferase
lete (1 -5). In addition, the extent of interference by hae- (EC 2.6.1.2), -glutamyltransferase (EC 2.3.2.2), alka-
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line phosphatase (EC 3.1.3.1)ra-amylase (EC 3.2.1.1),
lactate dehydrogenase (EC 1.1.1.27) and cholinesterase
(EC 3.1.1.8).
Materials and Methods
Apparatus
HDL- and LDL-cholesterol were determined manually using a
spectral line photometer 6118 (Eppendorf). Magnesium was deter-
mined with an Hitachi 704 analyser (Boehringer) with batchwise
processing of samples, while the other quantities were determined
in random access made with an Hitachi 737 analyser (Boehringer).
A spectrophotometer Lambda 5 (Perkin Elmer) was used for the
spectrophotometric determination of free haemoglobin.
Reagents
The reagents and methods used are shown in table 1. Free haemo-
globin in serum was determined spectrophotometrically according
to Harboe (6).
Samples
Venous blood samples (210 ml) were'drawn at 8.00 a.m. from
20 fasting, apparently healthy subjects in sitting position. For this
purpose, 10 ml Vacutainer® sample tubes with polyester separation
gel were used. These blood specimens were then randomised.
Eleven of the blood samples were centrifuged immediately for 10
minutes at 3400 g and one of the sera obtained was used for mea-
surement of the aforementioned quantities. Five serum tubes and 5
whole blood tubes were stored at room temperature (at 23-27 °C
in a dark cupboard) and the remaining 5 of each, at 9 °C in a dark
refrigerator. Centrifugation of the whole blood samples was
Tab. 1 Reagents and methods used in this study
Analyte
Sodium
Potassium
Calcium
Chloride
Inorganic
phosphate
Magnesium
Creatinine
Urea
Uric acid
Bilirubin
Cholesterol, total
HDL-cholesterol
LDL-cholesterol
Triacylglycerol
Creatine kinase
Aspartate
aminotransferase
AJanine
aminotransferase
γ-Glutamyl-
transferase
Alkaline
phosphatase
a-Amylase
Lactate
dehydrogenase
Cholinesterase
Method
Indirect potentiometry (Boehringer Mann-
heim GmbH, Mannheim, Germany)
Indirect potentiometry (Boehringer)
0-Cresolphthalein complexone (Boeh-
ringer)
Indirect potentiometry (Boehringer)
Ammonium molybdate (Boehringer)
Calmagite (Sigma Chemical Co., St. Louis
[U.S.A.])
Kinetic modification of the Jaffe method
(Boehringer)
Enzymatic kinetic UV test (Boehringer)
Enzymatic colorimetric test (Peridoch-
rom®) (Boehringer)
Dichlorphenyl diazonium method (Boeh-
ringer)
Enzymatic colorimetric test (CHOD-PAP
method) (E. Merck, Darmstadt, Germany)
Precipitation with phosphotungstic acioV
MgCl2 (Merck)
Precipitation with heparin at pH 5.12
(Merck)
Enzymatic colorimetric test (GPO-PAP
method) (Boehringer)
Optimised standard method** at + 25 °C
(Boehringer)
Optimised standard method** at + 25 °C
(Boehringer)
Optimised standard method** at + 25 °C
(Boehringer)
According to Szasz new at + 25 °C (Boeh-
ringer)
Optimised standard method** at + 25 °C
(Boehringer)
PNP method at + 25 °C (Boehringer)
Optimised standard method** at + 25 °C
(Boehringer)
Butyrylthiocholine iodide at + 25 °C
(Boehringer)
Catalogue
Number
(Reagent 1 and 2)
*
*
1127551 and 1127650
*
836281
595-A
11 279 18 and 1127926
112791 8 and 1127926
791679 and 120927
1127535 and 1127543
14164, 14165, 14166
and 14167
14210, 14164-67
14992, 14164-67
1128027 and 1201301
11 27586 and 109 1077
11 27802 and 1127829
11 27837 and 1127845
1127853 and 1127861
11 27454 and 79 1377
1209035 and 791393
1127969 and 1127977
11 27667 and 1127675
Inter-
assay-
impre-
cision
(%)
0.7
1.3
1.4
1.3
2.0
3.7
3.1
1.6
2.5
3.5
1.8
3.0
4.7
2.0
1.6
2.4
1.8
2.6
2.7
1.1
1.7
1.7
Maximum
allowable
inaccu-
racy
(%)
2.0
2.7
3.3
2.0
5.0
4.0
6.0
8.0
6.0
7.0
6.0
[6.0]
[6.0]
7.0
8.0
7.0
7.0
7.0
7.0
[7.0]
7.0
7.0
Day zero
(100% value
of figures 2 -5)
139.0 mmol/l
3.92 mmol/l
2.28 mmol/l
106.6 mmol/l
1.33 mmol/l
0.79 mmol/l
91.1 μηιοΐ/ΐ
5. 12 mmol/l
281.1 μηιοΐ/ΐ
9.49 μηιοΐ/ΐ
5.05 mmol/l
1.52 mmol/l
3. 10 mmol/l
1.25 mmol/l
43.3 U/l
9.10U/1
7.68 U/l
9.80 U/l
100.4 U/l
72.5 U/l
143.1 U/l
5082,2 U/I
* Ion-selective electrode of Hitachi 737
** according to the Recommendations of the German Society of Clinical Chemistry
For the numbers in brackets there are no limits defined. The limits were derived from other
or lipoproteins. enzymes
Eur J Clin Chem Clin Biochern 1995; 33 (No 4)
Heins et al.: Storage of serum or whole blood samples? 233
performed on the day of analysis. After 1, 2, 3, 4 and 7 days,
measurements of the quantities examined were repeated. To avoid
evaporation, sample tubes were kept closed until analysis.
Statistical analysis
The Friedman test was used to examine the influence of storage
time on the measurable quantities. The changes of the values after
storage were calculated for each subject as percentages of the ini-
tial values. The mean and standard deviation was computed and
plotted. SPSS for windows was used to compute the Friedman test
and Lotus 1-2-3 for OS/2 to calculate the percentage deviation.
Results
Release of haemoglobin
The release of free haemoglobin in whole blood samples
of 10 apparently healthy persons stored at 9 °C in a re-
frigerator and at room temperature in a dark cupboard is
shown in figure 1.
Storage of serum and whole blood
Significant changes in mean concentration or mean cata-
lytic concentration during storage, which exceeded the
maximum inaccuracy allowed by the Guidelines of the
German Federal Council (7), were shown by the
following quantities:
3.0
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1.0
0.70
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0.40
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0.02
0.01
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Fig. 1 Release of free haemoglobin during storage (circle at 9 °C,
square at room temperature) in clotted blood (n = 10). Values are
given in mean and standard deviation.
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Whole blood at room temperature
Sodium
Potassium
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Inorganic phosphate
Magnesium
Creatinine
Urea
HDL-cholesterol
LDL-cholesterol
Alanine aminotransferase
Alkaline phosphatase
a-Amylase
Lactate dehydrogenase
(decrease after 7 days)
(increase after 1 day)
(decrease after 3 days)
(decrease after 1 day)
(increase after 1 day)
(increase after 1 day)
(increase after 2 days)
(increase after 2 days)
(increase after 3 days)
(decrease after 2 days)
(decrease after 7 days)
(decrease after 7 days)
(decrease after 7 days)
(increase after 1 day)
Tlie changes in the measurable quantities are shown in
percentage of the initial value in figures 2-5.
Discussion
Several phenomena were observed during sample stor-
age. In serum, some analytes showed a decrease, others
an increase due to enzymatic cleavage of precursor
molecules. Prolonged contact of serum with red cells
resulted in an exchange of substances between serum
and the erythrocytes, which can cause dilution or can
Eur J Clin Chein Clin Biochem 1995; 33 (No 4)
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Fig. 2 Storage of centrifuged vacutainer® tubes at 9 °C. Devia-
tion of the measurable quantities as mean and standard deviation
in percentage of the initial value. From the top to the bottom: inor-
ganic phosphate (circle) and lactate dehydrogenase (square).
lead to an increase of analyte concentrations in the se-
rum. Haemolysis causes the release of erythrocytic con-
stituents, which can result in increased values or in dilu-
tion leading to decreased values. Haemoglobin may also
interfere in the measurement, e.g., in the photometric
quantification of constituents. This influence also de-
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Fig. 3 Storage of centrifuged vacutainer® tubes at room temper-
ature. Deviation of the measurable quantities as mean and standard
deviation in percentage of the initial value.
a) Electrolytes, trace elements and metabolites from top to bottom:
inorganic phosphate (circle), uric acid (square>and bilirubin (trian-
gle).
b) Lipids and lipoproteins from top to bottom: triacylglycerols
(hexagon), HDL-cholesterol (wedge) and LDL-cholesterol
(rhomb).
c) Enzymes from top to bottom: aspartate aminotransferase
(square) and creatine kinase (circle). · t
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Fig. 4 Storage of not centrifuged vacutainer® tubes at 9 °C. Devi-
ation of the measurable quantities s mean and standard deviation
in percentage of the initial value.
a) Electrolytes and trace elements from the top to the bottom: po-
tassium (square), inorganic phosphate (wedge), magnesium
(rhomb), chloride (triangle) and sodium (circle).
b) Metabolites and enzymes from the top to the bottom: lactate
dehydrogenase (wedge), uric acid (circle), creatinine (hexagon), a-
amylase (triangle) and alkaline phosphatase (square).
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Fig. 5 Storage of not centrifuged vacutainer® tubes at room tem-
perature. Deviation of the measurable quantities as mean and stan-
dard deviation in percentage of the initial value.
a) Electrolytes and trace elements from the top to the bottom: po-
tassium (square), inorganic phosphate (rhomb), magnesium (hexa-
gon), chloride (wedge), sodium (circle) and calcium (triangle).
b) Metabolites and lipoproteins from the top to the bottom: creati-
nine (wedge), urea (rhomb), HDL-cholesterol (hexagon) and LDL-
cholesterol (circle).
pends on the main and the sub-wavelengths at which the
measurement is performed. The above-mentioned in-
teractions in the preanalytical phase are difficult to de-
scribe, because not all influences can be simulated in
model experiments (2).
Electrolytes
Sodium, calcium and chloride concentrations decrease
in whole blood because these low molecular mass sub-
stances enter the erythrocytes under the influence of
their concentration gradients, namely 19 : 1 for sodium,
128 : 1 for calcium and 1.5 : 1 for chloride (8). Addition-
ally, potassium and magnesium ions pass through the
erythrocyte membrane due to the serum/erythrocyte ra-
tio of 1 : 20 or 1 :2.5. The slight increase in potassium
after storage of centrifuged tubes is caused by the small
number of erythrocytes on the surface of the polyester
separation gel. Due to the temperature-dependent activ-
ity of the Na+-K+-ATPase (9), there are fewer shifts of
sodium and potassium within the first 4 days, when
whole blood is stored at room temperature than when it
Eur J Clin Chem Ciin Biochem 1995; 33 (No 4)
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is stored at 9 °C. The phosphafases in serum and whole
blood cause a hydrolysis of phosphate esters, leading to
an increase in the inorganic phosphate concentration.
Since erythrocytes have an essentially higher concentra-
tion of phosphate esters, there is a greater increase in
whole blood than in serum (10, 11).
Metabolites
No clinically relevant instability was observed in creati-
nine in serum over a period of one week. When whole
blood was stored at room temperature, however, there
was an increase in the measured concentrations of this
analyte as a result of the non-specific formation of reac-
tants, the so-called pseudocreatinines (12), for example,
pyruvate from erythrocyte metabolism (13). Storage of
whole blood at 9 °C had a slight adverse effect on the
creatinine concentration indicating that this non-specific
interference is influenced by temperature.
Urea in serum was found to be stable for one week. In
the uncentrifuged tubes, cleavage of ammonia from ba-
sic amino acids may cause a slight interference with re-
spect to the urease/glutamate dehydrogenase reaction.
As a result, an apparent continuous increase in urea con-
centration in whole blood was observed at room temper-
ature.
A small continuous increase in uric acid was observed
in serum. In whole blood, haemoglobin may interfere
in the measurement of this analyte, since haemoglobin
interferes directly with the peridochrom method by
spectral interference at 570 nm. In contrast, Keller (3)
found a decrease in uric acid in plasma and whole blood,
and Sonntag (2) reported a negative interference by hae-
molysis.
The instability of bilirubin in serum is caused by photo-
oxidation. Additionally, in whole blood, the dichloro-
phenyl diazonium method (15) (a modified Evelyn-Mal-
loy method) showed a positive interference by haemo-
globin, in contrast to the Jendrassik Grof method as re-
ported by other authors (1-3, 16). Thus the decrease
was compensated by the release of haemoglobin and
there was no significant increase in the values.
Lipids
In serum, cholesterol, as well as HDL- and LDL-choles-
terol concentrations, showed no significant shift during
storage in the refrigerator over a period of 7 days. Other
authors obtained the same results using polyethylene
glycol 6000 as precipitating agent (17). In contrast,
Khan & Elkeles (18) observed a decrease in the HDL-
cholesterol concentration, using heparin manganese/
dextran sulphate for precipitation. Storage of serum at
room temperature produced adverse changes, i.e. an
increase in the HDL- and a decrease in the LDL-choles-
terol concentration, because of incomplete precipitation
of LDL- and VLDL-lipoproteins (19, 20). The signifi-
cant rise in cholesterol and HDL-cholesterol (and the
decrease in LDL-cholesterol, whiqh is partially compen-
sated in whole blood but not in serum) in whole blood
at room temperature resulted from an increase in
cholesteryl esters accompanied by a smaller decrease in
free cholesterol. This change seems to be a lecithin-cho-
lesterol acyltransferase-dependent (EC 2.3.1.43) choles-
terol transport out of blood cells (21). A significant drift
in the triacylglycerol concentration was observed at
room temperature. This apparent increase could be
caused by cleavage of glycerol from phospholipids.
Enzymes
Inactivation of creatine kinase in serum increases with
temperature and bright sunlight. This effect is not re-
versed by addition of sulphydryl (thiol) compounds. Ox-
idation of the sulphydryl groups in the active centre,
which also causes an inactivation of the enzyme, is re-
versible. In an optimised assay, containing EDTA to re-
verse creatine kinase inhibition by calcium ions, and N-
acetylcysteine to reactivate the sulphydryl groups, cre-
atine kinase is reactivated by 97% (22) or to 99% (23).
Thus, in contrast to earlier studies, reactivation of the
creatine kinase activity by prior addition of thiol rea-
gents to the sample is not necessary, but in the absence
of such an addition we observed a greater decrease in
enzyme activity with storage (24).
In whole blood, interference of adenylate kinase re-
leased by haemolysis of erythrocytes is inhibited by in-
cluding diadenosine pentaphosphate and adenosine mo-
nophosphate in the reagent. We determined only a mod-
erate temperature-dependent compensation of creatine
kinase inactivation caused by other intermediates and
enzymes from the erythrocytes, compared with methods
using no inhibitor (25). In spite of the inhibitors added
in the optimised assay, a high amount of adenylate ki-
nase can also cause an increase in the catalytic concen-
tration of creatine kinase (26).
In serum, a temperature-dependent decrease of aspartate
aminotransferase was observed. At 9 °C, the enzyme
was stable over 7 days. At room temperature, a slight
continuous loss of activity occurred. Similar results have
been described by Cuccherini (27) with a smaller de-
cline in activity at lower temperatures! Samples with ab-
normal values showed a greater decrease. Schmidt (24)
has» also described a higher temperature-dependent
decrease during storage. In whole blood, the measured
aspartate aminotransferase activities did not increase
Eur J Clin Chem Clin Biochem 1995; 33 (No 4)
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significantly over a period of 7 days. The increase was
higher at 9 °C than at room temperature. This was obvi-
ously due to the greater stability of the enzyme. A non-
significant increase due to haemolysis has been de-
scribed by Yücel et al. (28). In model experiments other
authors have observed a greater increase, due to haemo-
lysis and 40-fold higher activity of aspartate aminotrans-
ferase in erythrocytes compared with serum (2, 25).
The alanine aminotransferase stability observed in serum
corresponds to the data provided by Williams et al. (29),
but the decrease at 9 °C and at room temperature was
not significant over a period of 7 days. As far as whole
blood is concerned, our results agree with the data con-
firmed by Ruby et al. (30), who found a greater loss of
activity at room temperature than at 4 °C, but in our
study the latter had no statistical significance. Cuccher-
ini (27) has shown that the loss of activity in pathologi-
cal samples is higher than in samples with a normal ala-
nine aminotransferase activity.
Only the measurements of -glutamyltransferase after
storage of whole blood at room temperature showed any
significant alteration in enzyme activity. The distinct rise
in haemolysis causes the release of glutathione, which
inhibits enzyme activity at day 7 (31). Persjin & van
der Slik (32) found interference by relatively high hae-
moglobin concentrations in this method.
Alkaline phosphatase showed a significant decrease after
storage in whole blood. -Amylase is stable in serum for
one week, while in whole blood, the activity strongly
decreased after 7 days at room temperature. The binding
of p-nitrophenol to haemoglobin is highly dependent on
the pH value of the test system. Therefore, the determi-
nation of enzyme activity based on the release of this
substance is especially prone to interference at high pH
values. This may explain a more marked decrease in the
measured catalytic concentrations of alkaline phospha-
tase compared with that of a-amylase (2).
The slight but significant decrease in lactate dehydroge-
nase activity in serum at 9 °C is caused by an instability
of the isoforms lactate dehydrogenase 3, lactate dehy-
drogenase 4 and lactate dehydrogenase 5 in the cold
state (33). At room temperature, no significant change
could be detected. In whole blood, a rapid increase in
activity was observed because lactate dehydrogenase ac-
tivity is 260 times higher in erythrocytes than in serum
(34).
There were no clinically relevant differences in cholin-
esterase activity, either in serum over a period of 7 days
or in whole blood over 4 days. Similar results were ob-
tained by Bailand et al. (35).
Conclusions
Our study confirmed that blood samples should gen-
erally be centrifuged as soon as possible. All measurable
quantities examined were stable for four days in sepa-
rated serum at 9 °C; however, values of inorganic phos-
phate, uric acid, bilirubin, triacylglycerols, HDL- and
LDL-cholesterol and creatine kinase were not suffi-
ciently stable when serum was stored at room temper-
ature. If centrifugation is not possible within 24 h, chlo-
ride, inorganic phosphate, magnesium and -gluta-
myltransferase exceed the limits of stability when the
samples are stored at room temperature. At 9 °C the lat-
ter are stable, but sodium, creatinine and alkaline phos-
phatase exceed the limits.
For the determination of potassium or lactate dehydroge-
nase in serum the storage of whole blood samples seems
not to be acceptable.
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